Correlation Engine 2.0
Clear Search sequence regions


  • baculovirus (1)
  • cells human (1)
  • cricetulus (1)
  • escherichia coli (1)
  • glycan (1)
  • glycoprotein (7)
  • hamster (3)
  • human (2)
  • insect (1)
  • native (1)
  • ovary (2)
  • pichia (1)
  • vaccines (1)
  • Sizes of these terms reflect their relevance to your search.

    This chapter is intended to provide insights for researchers aiming to choose an appropriate expression system for the production of recombinant glycoproteins. Producing glycoproteins is complex, as glycosylation patterns are determined by the availability and abundance of specific enzymes rather than a direct genetic blueprint. Furthermore, the cell systems often employed for protein production are evolutionarily distinct, leading to significantly different glycosylation when utilized for glycoprotein production. The selection of an appropriate production system depends on the intended applications and desired characteristics of the protein. Whether the goal is to produce glycoproteins mimicking native conditions or to intentionally alter glycan structures for specific purposes, such as enhancing immunogenicity in vaccines, understanding glycosylation present in the different systems and in different growth conditions is essential. This chapter will cover Escherichia coli, baculovirus/insect cell systems, Pichia pastoris, as well as different mammalian cell culture systems including Chinese hamster ovary (CHO) cells, human endothelial kidney (HEK) cell lines, and baby hamster kidney (BHK) cells. © 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

    Citation

    Elizabeth C Clarke. Considerations for Glycoprotein Production. Methods in molecular biology (Clifton, N.J.). 2024;2762:329-351

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38315375

    View Full Text